Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ward

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Trends in Immunology|April 23, 2004
Do phosphoinositide 3-kinases direct lymphocyte navigation?Stephen G Ward
Trends in Immunology|January 18, 2006
T lymphocytes on the move: chemokines, PI 3-kinase and beyondStephen G Ward
Current Topics in Microbiology and Immunology|October 15, 2022
The Role of PI3K Isoforms in Autoimmune DiseaseStephen G Ward
Immunity|March 24, 2009
Millipede-like lymphocyte crawling: feeling the way with filopodiaStephen G Ward
Current Opinion in Pharmacology|August 7, 2003
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agentsStephen G Ward, Peter Finan
Current Opinion in Pharmacology|October 28, 2009
New insights into mechanisms of gastrointestinal inflammation and cancerStephen G Ward, Randall Mrsny
Current Opinion in Pharmacology|April 10, 2012
Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemiaMatthew D Blunt, Stephen G Ward
Journal of Immunological Methods|January 22, 2003
Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signalingAdam P Curnock, Stephen G Ward
Frontiers in Immunology|August 10, 2012
Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunitiesMatthew D Blunt, Stephen G Ward
Trends in Immunology|February 26, 2010
Protein arginine methylation: a new handle on T lymphocytes?Richard V Parry, Stephen G Ward
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Trends in Immunology|April 23, 2004
Do phosphoinositide 3-kinases direct lymphocyte navigation?Stephen G Ward
Trends in Immunology|January 18, 2006
T lymphocytes on the move: chemokines, PI 3-kinase and beyondStephen G Ward
Current Topics in Microbiology and Immunology|October 15, 2022
The Role of PI3K Isoforms in Autoimmune DiseaseStephen G Ward
Immunity|March 24, 2009
Millipede-like lymphocyte crawling: feeling the way with filopodiaStephen G Ward
Current Opinion in Pharmacology|August 7, 2003
Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agentsStephen G Ward, Peter Finan
Current Opinion in Pharmacology|October 28, 2009
New insights into mechanisms of gastrointestinal inflammation and cancerStephen G Ward, Randall Mrsny
Current Opinion in Pharmacology|April 10, 2012
Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemiaMatthew D Blunt, Stephen G Ward
Journal of Immunological Methods|January 22, 2003
Development and characterisation of tetracycline-regulated phosphoinositide 3-kinase mutants: assessing the role of multiple phosphoinositide 3-kinases in chemokine signalingAdam P Curnock, Stephen G Ward
Frontiers in Immunology|August 10, 2012
Pharmacological targeting of phosphoinositide lipid kinases and phosphatases in the immune system: success, disappointment, and new opportunitiesMatthew D Blunt, Stephen G Ward
Trends in Immunology|February 26, 2010
Protein arginine methylation: a new handle on T lymphocytes?Richard V Parry, Stephen G Ward
Pageof 7